LLY Total Debt
Short-term plus long-term borrowings at each quarter end, before any offset for cash.
Total Debt
Latest: $54.91B (2026Q2)
| Period | Value |
|---|---|
| 2024Q1 | $26.21B |
| 2024Q2 | $28.89B |
| 2024Q3 | $31.12B |
| 2024Q4 | $33.64B |
| 2025Q1 | $38.52B |
| 2025Q2 | $39.90B |
| 2025Q3 | $42.51B |
| 2025Q4 | $42.50B |
| 2026Q1 | $43.37B |
| 2026Q2 | $54.91B |
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Rule of 40
Healthcare Comparison
1 / 3
Latest Total Debt: $54.91B (2026Q2); +37.6% YoY.
Across the 10 quarters from 2024Q1 to 2026Q2, Total Debt ranged from $26.21B in 2024Q1 to $54.91B in 2026Q2.